Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 579, Pages eabb6282
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-02-04
DOI
10.1126/scitranslmed.abb6282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets
- (2020) Ming Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
- (2020) Katharina Reinhard et al. SCIENCE
- Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
- (2020) Michael S Lee et al. LANCET ONCOLOGY
- An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma
- (2019) Renata Sano et al. Science Translational Medicine
- Antibody-Drug Conjugate-Based Therapeutics: State of the Science
- (2019) Michael J Birrer et al. JNCI-Journal of the National Cancer Institute
- Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy
- (2019) Elisa Lozano et al. HEPATOLOGY
- Cellular Plasticity in Cancer
- (2019) Salina Yuan et al. Cancer Discovery
- Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
- (2019) Liguo Zhang et al. CANCER CELL
- ZO-2 Is a Master Regulator of Gene Expression, Cell Proliferation, Cytoarchitecture, and Cell Size
- (2019) Lorenza González-Mariscal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets
- (2019) Heng Liang Tan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour evolution in hepatocellular carcinoma
- (2019) Amanda J. Craig et al. Nature Reviews Gastroenterology & Hepatology
- Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
- (2019) Alexandre Teixeira Vessoni et al. ONCOGENE
- Claudin-18–mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis
- (2018) Beiyun Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hippo Pathway: Biology and Pathophysiology
- (2018) Shenghong Ma et al. Annual Review of Biochemistry
- Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
- (2018) Marissa Spino et al. CLINICAL CANCER RESEARCH
- Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs
- (2018) Yosuke Hashimoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
- (2017) Sachin H. Patel et al. GASTROENTEROLOGY
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
- (2017) Amy S. Farrell et al. Nature Communications
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway
- (2016) Alaide Domínguez-Calderón et al. MOLECULAR BIOLOGY OF THE CELL
- Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
- (2016) Itay Tirosh et al. NATURE
- Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation
- (2016) Laura Broutier et al. Nature Protocols
- Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers
- (2016) Zhixin Qiu et al. Scientific Reports
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
- (2015) Meritxell Huch et al. CELL
- Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap
- (2015) Aleksander D. Szymaniak et al. DEVELOPMENTAL CELL
- YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
- (2015) Julien Fitamant et al. Cell Reports
- Hippo Pathway Activity Influences Liver Cell Fate
- (2014) Dean Yimlamai et al. CELL
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
- (2013) Leilei Chen et al. NATURE MEDICINE
- Physiological Oxygen Prevents Frequent Silencing of theDLK1-DIO3Cluster during Human Embryonic Stem Cells Culture
- (2013) Pingyuan Xie et al. STEM CELLS
- Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells
- (2013) Uri Ben-David et al. Nature Communications
- NHLBI-AbDesigner: an online tool for design of peptide-directed antibodies
- (2011) Trairak Pisitkun et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
- (2011) N.-G. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physicochemical Stability of the Antibody−Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
- (2010) Aditya A. Wakankar et al. BIOCONJUGATE CHEMISTRY
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
- The stem cell niche of human livers: Symmetry between development and regeneration
- (2008) Lili Zhang et al. HEPATOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started